ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 7 NDC API, 1 Listed Suppliers

1 API Suppliers
7 NDC API
1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 3 FDA Orange Book, 3 Europe

6 FDF Dossiers
3 FDA Orange Book
3 Europe

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
1 NEWS #PharmaBuzz

MARKET PLACE

1 FDF Dossiers

marketPlace
1 FDF Dossiers

Nortec Quimica Olanzapine Pamoate

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₄₀H₃₈N₄O₇S

Molecular Weight

718.8 g/mol

InChI Key

IZXGHRZKSNKYIY-UHFFFAOYSA-N

1 2D Structure

Olanzapine Pamoate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid;2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine;hydrate

2.1.2 InChI

InChI=1S/C23H16O6.C17H20N4S.H2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12;/h1-10,24-25H,11H2,(H,26,27)(H,28,29);3-6,11,18H,7-10H2,1-2H3;1H2

2.1.3 InChI Key

IZXGHRZKSNKYIY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.O

2.1.5 Isomeric SMILES

CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.O

2.2 Create Date

2007-12-05

3 Chemical and Physical Properties

Molecular Formula	C₄₀H₃₈N₄O₇S
Molecular Weight	718.8 g/mol
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	12
Rotatable Bond Count	5
Exact Mass	718.24612074 g/mol
Monoisotopic Mass	718.24612074 g/mol
Topological Polar Surface Area	172 A^2
Heavy Atom Count	52
Formal Charge	0
Complexity	1110
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Zyprexa relprevv
Active Ingredient	Olanzapine pamoate
Dosage Form	Suspension, extended release
Route	Intramuscular
Strength	eq 300mg base/vial; eq 210mg base/vial; eq 405mg base/vial
Market Status	Prescription
Company	Eli Lilly

2 of 2
Drug Name	Zyprexa relprevv
Active Ingredient	Olanzapine pamoate
Dosage Form	Suspension, extended release
Route	Intramuscular
Strength	eq 300mg base/vial; eq 210mg base/vial; eq 405mg base/vial
Market Status	Prescription
Company	Eli Lilly